# INdians Followed for INtensive Lipid Lowering Treatment and Its safetY

> **NCT00664469** · PHASE3 · TERMINATED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 64 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** ezetimibe
- **DRUG:** Comparator: Simvastatin 20, 40 and 80 mg
- **DRUG:** Comparator: Atorvastatin
- **DRUG:** Comparator: Rosuvastatin

## Key facts

- **NCT ID:** NCT00664469
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-11
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2011-07-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664469, "INdians Followed for INtensive Lipid Lowering Treatment and Its safetY". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00664469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*